Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot
This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions
| Active as of 2022-01-10 |
<Citation xmlns="http://hl7.org/fhir">
<id value="58"/>
<meta>
<versionId value="24"/>
<lastUpdated value="2023-12-06T00:56:00.523Z"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Citation</b><a name="58"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Citation "58" Version "24" Updated "2023-12-06 00:56:00+0000" </p></div><p><b>StructureDefinition Work Group</b>: cds</p><p><b>url</b>: <code>https://fevir.net/resources/Citation/58</code></p><p><b>identifier</b>: FEvIR Object Identifier: 58</p><p><b>version</b>: 1.0.0-ballot</p><p><b>title</b>: Citation for FEvIR Evidence 55: 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)</p><p><b>status</b>: active</p><p><b>date</b>: 2022-01-10 13:29:15+0000</p><p><b>publisher</b>: HL7 International / Clinical Decision Support</p><p><b>contact</b>: HL7 International / Clinical Decision Support: <a href="http://www.hl7.org/Special/committees/dss">http://www.hl7.org/Special/committees/dss</a></p><p><b>description</b>: This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide.</p><h3>UseContexts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style="display: none">*</td><td>FEvIR Platform Use (Details: http://hl7.org/fhir/citation-classification-type code fevir-platform-use = 'FEvIR Platform Use', stated as 'FEvIR Platform Use')</td><td>FHIR Resource <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-citation-artifact-classifier.html">Citation Artifact Classifier</a>#fhir-resource)</span></td></tr></table><p><b>jurisdiction</b>: World <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (m49.htm#001)</span></p><p><b>copyright</b>: https://creativecommons.org/licenses/by-nc-sa/4.0/</p><p><b>author</b>: Brian S. Alper: </p><h3>Summaries</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Style</b></td><td><b>Text</b></td></tr><tr><td style="display: none">*</td><td>Computable Publishing <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-citation-summary-style.html">Citation Summary Style</a>#comppub)</span></td><td>14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) [FHIR Resource], version 4. Contributors: Brian S. Alper, Joanne Dehnbostel, Khalid Shahin [Authors]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 55. Created December 17, 2020. Revised December 21, 2020. Accessed March 13, 2021. Available at: https://fevir.net/resources/Evidence/55. Computable resource at: https://fevir.net/resources/Evidence/55.</td></tr></table><h3>RelatedArtifacts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>ResourceReference</b></td></tr><tr><td style="display: none">*</td><td>derived-from</td><td><a href="https://fevir.net/resources/Evidence/55">https://fevir.net/resources/Evidence/55</a> "Fourteen_day_mortality_remdesivir_vs_placebo_meta_analysis_ACTT_1_Wang_et_al_WHO_SOLIDARITY"</td></tr></table><blockquote><p><b>citedArtifact</b></p><p><b>identifier</b>: FEvIR Object Identifier: 55</p><p><b>dateAccessed</b>: 2021-03-13</p><h3>Versions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Value</b></td></tr><tr><td style="display: none">*</td><td>4</td></tr></table><h3>StatusDates</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Activity</b></td><td><b>Actual</b></td><td><b>Period</b></td></tr><tr><td style="display: none">*</td><td>Created <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-cited-artifact-status-type.html">Cited Artifact Status Type</a>#created)</span></td><td>true</td><td>?? --> 2020-12-17</td></tr></table><h3>Titles</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Language</b></td><td><b>Text</b></td></tr><tr><td style="display: none">*</td><td>Primary title <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-title-type.html">Title Type</a>#primary)</span></td><td>English <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (Tags for the Identification of Languages[4.0.1]#en)</span></td><td>14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY).</td></tr></table><h3>Abstracts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Language</b></td><td><b>Text</b></td><td><b>Copyright</b></td></tr><tr><td style="display: none">*</td><td>Primary human use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-cited-artifact-abstract-type.html">Cited Artifact Abstract Type</a>#primary-human-use)</span></td><td>English <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-ietf3066.html">Tags for the Identification of Languages</a>#en)</span></td><td>COVID-19 pneumonia remdesivir vs. placebo 14-day mortality (779 events among 6,744 participants, 3 randomized trials)\nRisk ratio 0.85 (95% CI 0.74 to 0.96) in fixed-effect analysis\nRisk ratio 0.81 (95% CI 0.60 to 1.08) in random-effects analysis</td><td>https://creativecommons.org/licenses/by-nc-sa/4.0/</td></tr></table><blockquote><p><b>publicationForm</b></p><h3>PublishedIns</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Title</b></td><td><b>Publisher</b></td><td><b>PublisherLocation</b></td></tr><tr><td style="display: none">*</td><td>Database <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-published-in-type.html">Published In Type</a>#D019991)</span></td><td>Fast Evidence Interoperability Resources (FEvIR) Platform</td><td><span>: Computable Publishing LLC</span></td><td>Ipswich, MA, USA</td></tr></table><p><b>lastRevisionDate</b>: 2020-12-21</p><p><b>language</b>: English <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (Tags for the Identification of Languages[4.0.1]#en)</span></p><p><b>copyright</b>: https://creativecommons.org/licenses/by-nc-sa/4.0/</p></blockquote><h3>WebLocations</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Classifier</b></td><td><b>Url</b></td></tr><tr><td style="display: none">*</td><td>JSON <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-url-classifier.html">Artifact Url Classifier</a>#json)</span>, Computable resource <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-url-classifier.html">Artifact Url Classifier</a>#computable-resource)</span></td><td><a href="Evidence-55.html">14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)</a></td></tr></table><blockquote><p><b>classification</b></p><p><b>type</b>: Knowledge Artifact Type <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-cited-artifact-classification-type.html">Cited Artifact Classification Type</a>#knowledge-artifact-type)</span></p><p><b>classifier</b>: FHIR Resource <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-citation-artifact-classifier.html">Citation Artifact Classifier</a>#fhir-resource)</span></p></blockquote><blockquote><p><b>classification</b></p><p><b>type</b>: FHIR Resource <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-citation-artifact-classifier.html">Citation Artifact Classifier</a>#fhir-resource)</span></p><p><b>classifier</b>: Evidence <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-fhir-types.html">All FHIR Types</a>#Evidence)</span></p></blockquote><blockquote><p><b>classification</b></p><p><b>type</b>: keyword major topic <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-179423.html">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#defined-in-text "Defined in text")</span></p><p><b>classifier</b>: remdesivir <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-179423.html">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#defined-in-text "Defined in text")</span>, COVID-19 <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-179423.html">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#defined-in-text "Defined in text")</span>, pharmaceutical treatment <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-179423.html">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#defined-in-text "Defined in text")</span></p></blockquote><blockquote><p><b>contributorship</b></p><p><b>complete</b>: true</p><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a name="contributor0"> </a></p><blockquote><p/><p><a name="contributor0"> </a></p><p><b>identifier</b>: id: 0000-0003-4300-4928</p><p><b>name</b>: Brian S. Alper </p><p><b>telecom</b>: <a href="mailto:balper@computablepublishing.com">balper@computablepublishing.com</a></p></blockquote><p><b>forenameInitials</b>: BS</p><p><b>affiliation</b>: <span>: Computable Publishing LLC</span></p><p><b>contributionType</b>: Conceptualization <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#conceptualization)</span>, Data curation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#data-curation)</span>, Supervision <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#supervision)</span></p><p><b>role</b>: Author/Creator <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-contributor-role.html">Contributor Role</a>#author)</span></p><p><b>correspondingContact</b>: true</p></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a name="contributor1"> </a></p><blockquote><p/><p><a name="contributor1"> </a></p><p><b>name</b>: Joanne Dehnbostel </p><p><b>telecom</b>: <a href="mailto:jdehnbostel@computablepublishing.com">jdehnbostel@computablepublishing.com</a></p></blockquote><p><b>forenameInitials</b>: J</p><p><b>affiliation</b>: <span>: Computable Publishing LLC</span></p><p><b>contributionType</b>: Formal analysis <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#formal-analysis)</span>, Data curation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#data-curation)</span></p><p><b>role</b>: Author/Creator <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-contributor-role.html">Contributor Role</a>#author)</span></p><p><b>correspondingContact</b>: false</p></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a name="contributor2"> </a></p><blockquote><p/><p><a name="contributor2"> </a></p><p><b>name</b>: Khalid Shahin </p><p><b>telecom</b>: <a href="mailto:kshahin@computablepublishing.com">kshahin@computablepublishing.com</a></p></blockquote><p><b>forenameInitials</b>: K</p><p><b>affiliation</b>: <span>: Computable Publishing LLC</span></p><p><b>contributionType</b>: Software <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html">Artifact Contribution Type</a>#software)</span></p><p><b>role</b>: Author/Creator <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-contributor-role.html">Contributor Role</a>#author)</span></p><p><b>correspondingContact</b>: false</p></blockquote></blockquote></blockquote><hr/><blockquote><p><b>Generated Narrative: Practitioner #contributor0</b><a name="contributor0"> </a></p><p><b>identifier</b>: id: 0000-0003-4300-4928</p><p><b>name</b>: Brian S. Alper </p><p><b>telecom</b>: <a href="mailto:balper@computablepublishing.com">balper@computablepublishing.com</a></p></blockquote><hr/><blockquote><p><b>Generated Narrative: Practitioner #contributor1</b><a name="contributor1"> </a></p><p><b>name</b>: Joanne Dehnbostel </p><p><b>telecom</b>: <a href="mailto:jdehnbostel@computablepublishing.com">jdehnbostel@computablepublishing.com</a></p></blockquote><hr/><blockquote><p><b>Generated Narrative: Practitioner #contributor2</b><a name="contributor2"> </a></p><p><b>name</b>: Khalid Shahin </p><p><b>telecom</b>: <a href="mailto:kshahin@computablepublishing.com">kshahin@computablepublishing.com</a></p></blockquote></div>
</text>
<contained>
<Practitioner>
<id value="contributor0"/>
<identifier>
<system value="https://orcid.org/"/>
<value value="0000-0003-4300-4928"/>
<assigner>
<display value="ORCID"/>
</assigner>
</identifier>
<name>
<family value="Alper"/>
<given value="Brian S."/>
</name>
<telecom>
<system value="email"/>
<value value="balper@computablepublishing.com"/>
</telecom>
</Practitioner>
</contained>
<contained>
<Practitioner>
<id value="contributor1"/>
<name>
<family value="Dehnbostel"/>
<given value="Joanne"/>
</name>
<telecom>
<system value="email"/>
<value value="jdehnbostel@computablepublishing.com"/>
</telecom>
</Practitioner>
</contained>
<contained>
<Practitioner>
<id value="contributor2"/>
<name>
<family value="Shahin"/>
<given value="Khalid"/>
</name>
<telecom>
<system value="email"/>
<value value="kshahin@computablepublishing.com"/>
</telecom>
</Practitioner>
</contained>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
<valueCode value="cds"/>
</extension>
<url value="https://fevir.net/resources/Citation/58"/>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net"/>
<value value="58"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<version value="1.0.0-ballot"/>
<title
value="Citation for FEvIR Evidence 55: 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)"/>
<status value="active"/>
<date value="2022-01-10T13:29:15.764Z"/>
<publisher value="HL7 International / Clinical Decision Support"/>
<contact>
<name value="HL7 International / Clinical Decision Support"/>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/dss"/>
</telecom>
</contact>
<description
value="This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide."/>
<useContext>
<code>
<system value="http://hl7.org/fhir/citation-classification-type"/>
<code value="fevir-platform-use"/>
<display value="FEvIR Platform Use"/>
</code>
<valueCodeableConcept>
<coding>
<system value="http://hl7.org/fhir/citation-artifact-classifier"/>
<code value="fhir-resource"/>
<display value="FHIR Resource"/>
</coding>
</valueCodeableConcept>
</useContext>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="001"/>
<display value="World"/>
</coding>
</jurisdiction>
<copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
<author>
<name value="Brian S. Alper"/>
</author>
<summary>
<style>
<coding>
<system value="http://hl7.org/fhir/citation-summary-style"/>
<code value="comppub"/>
<display value="Computable Publishing"/>
</coding>
</style>
<text
value="14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) [FHIR Resource], version 4. Contributors: Brian S. Alper, Joanne Dehnbostel, Khalid Shahin [Authors]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 55. Created December 17, 2020. Revised December 21, 2020. Accessed March 13, 2021. Available at: https://fevir.net/resources/Evidence/55. Computable resource at: https://fevir.net/resources/Evidence/55."/>
</summary>
<relatedArtifact>
<type value="derived-from"/>
<resourceReference>🔗
<reference value="https://fevir.net/resources/Evidence/55"/>
<type value="Evidence"/>
</resourceReference>
</relatedArtifact>
<citedArtifact>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net"/>
<value value="55"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<dateAccessed value="2021-03-13"/>
<version>
<value value="4"/>
</version>
<statusDate>
<activity>
<coding>
<system value="http://hl7.org/fhir/cited-artifact-status-type"/>
<code value="created"/>
<display value="Created"/>
</coding>
</activity>
<actual value="true"/>
<period>
<end value="2020-12-17"/>
</period>
</statusDate>
<title>
<type>
<coding>
<system value="http://hl7.org/fhir/title-type"/>
<code value="primary"/>
<display value="Primary title"/>
</coding>
</type>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<version value="4.0.1"/>
<code value="en"/>
<display value="English"/>
</coding>
</language>
<text
value="14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)."/>
</title>
<abstract>
<type>
<coding>
<system value="http://hl7.org/fhir/cited-artifact-abstract-type"/>
<code value="primary-human-use"/>
<display value="Primary human use"/>
</coding>
</type>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="en"/>
<display value="English"/>
</coding>
</language>
<text
value="COVID-19 pneumonia remdesivir vs. placebo 14-day mortality (779 events among 6,744 participants, 3 randomized trials)\nRisk ratio 0.85 (95% CI 0.74 to 0.96) in fixed-effect analysis\nRisk ratio 0.81 (95% CI 0.60 to 1.08) in random-effects analysis"/>
<copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
</abstract>
<publicationForm>
<publishedIn>
<type>
<coding>
<system value="http://hl7.org/fhir/published-in-type"/>
<code value="D019991"/>
<display value="Database"/>
</coding>
</type>
<title
value="Fast Evidence Interoperability Resources (FEvIR) Platform"/>
<publisher>
<type value="Organization"/>
<display value="Computable Publishing LLC"/>
</publisher>
<publisherLocation value="Ipswich, MA, USA"/>
</publishedIn>
<lastRevisionDate value="2020-12-21"/>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<version value="4.0.1"/>
<code value="en"/>
<display value="English"/>
</coding>
</language>
<copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
</publicationForm>
<webLocation>
<classifier>
<coding>
<system value="http://hl7.org/fhir/artifact-url-classifier"/>
<code value="json"/>
<display value="JSON"/>
</coding>
</classifier>
<classifier>
<coding>
<system value="http://hl7.org/fhir/artifact-url-classifier"/>
<code value="computable-resource"/>
<display value="Computable resource"/>
</coding>
</classifier>
<url value="https://fevir.net/resources/Evidence/55"/>
</webLocation>
<classification>
<type>
<coding>
<system
value="http://hl7.org/fhir/cited-artifact-classification-type"/>
<code value="knowledge-artifact-type"/>
<display value="Knowledge Artifact Type"/>
</coding>
</type>
<classifier>
<coding>
<system value="http://hl7.org/fhir/citation-artifact-classifier"/>
<code value="fhir-resource"/>
<display value="FHIR Resource"/>
</coding>
</classifier>
</classification>
<classification>
<type>
<coding>
<system value="http://hl7.org/fhir/citation-artifact-classifier"/>
<code value="fhir-resource"/>
<display value="FHIR Resource"/>
</coding>
</type>
<classifier>
<coding>
<system value="http://hl7.org/fhir/fhir-types"/>
<code value="Evidence"/>
<display value="Evidence"/>
</coding>
</classifier>
</classification>
<classification>
<type>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="defined-in-text"/>
<display value="Defined in text"/>
</coding>
<text value="keyword major topic"/>
</type>
<classifier>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="defined-in-text"/>
<display value="Defined in text"/>
</coding>
<text value="remdesivir"/>
</classifier>
<classifier>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="defined-in-text"/>
<display value="Defined in text"/>
</coding>
<text value="COVID-19"/>
</classifier>
<classifier>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="defined-in-text"/>
<display value="Defined in text"/>
</coding>
<text value="pharmaceutical treatment"/>
</classifier>
</classification>
<contributorship>
<complete value="true"/>
<entry>
<contributor>
<reference value="#contributor0"/>
<type value="Practitioner"/>
</contributor>
<forenameInitials value="BS"/>
<affiliation>
<display value="Computable Publishing LLC"/>
</affiliation>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="conceptualization"/>
<display value="Conceptualization"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="data-curation"/>
<display value="Data curation"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="supervision"/>
<display value="Supervision"/>
</coding>
</contributionType>
<role>
<coding>
<system value="http://hl7.org/fhir/contributor-role"/>
<code value="author"/>
<display value="Author/Creator"/>
</coding>
</role>
<correspondingContact value="true"/>
</entry>
<entry>
<contributor>
<reference value="#contributor1"/>
<type value="Practitioner"/>
</contributor>
<forenameInitials value="J"/>
<affiliation>
<display value="Computable Publishing LLC"/>
</affiliation>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="formal-analysis"/>
<display value="Formal analysis"/>
</coding>
</contributionType>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="data-curation"/>
<display value="Data curation"/>
</coding>
</contributionType>
<role>
<coding>
<system value="http://hl7.org/fhir/contributor-role"/>
<code value="author"/>
<display value="Author/Creator"/>
</coding>
</role>
<correspondingContact value="false"/>
</entry>
<entry>
<contributor>
<reference value="#contributor2"/>
<type value="Practitioner"/>
</contributor>
<forenameInitials value="K"/>
<affiliation>
<display value="Computable Publishing LLC"/>
</affiliation>
<contributionType>
<coding>
<system value="http://hl7.org/fhir/artifact-contribution-type"/>
<code value="software"/>
<display value="Software"/>
</coding>
</contributionType>
<role>
<coding>
<system value="http://hl7.org/fhir/contributor-role"/>
<code value="author"/>
<display value="Author/Creator"/>
</coding>
</role>
<correspondingContact value="false"/>
</entry>
</contributorship>
</citedArtifact>
</Citation>
IG © 2022+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#1.0.0-ballot based on FHIR 5.0.0. Generated 2023-12-17
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change